Black Diamond Therapeutics Inc (BDTX) Stock: Navigating a Year of Stock Volatility

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Black Diamond Therapeutics Inc’s current trading price is -36.57% away from its 52-week high, while its distance from the 52-week low is 256.12%. The stock’s price range over this period has fluctuated between $1.22 and $6.85. The company, operating within the financial sector, had a trading volume of approximately 1.38 million for the day, which was noticeably higher than the average daily share volume of 0.51 million over the last 3 months.

Black Diamond Therapeutics Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $6.85 on 06/27/23 and the lowest value was $1.22 on 03/10/23.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Black Diamond Therapeutics Inc (BDTX) has experienced a quarterly rise of 138.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 224.36M and boasts a workforce of 65 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.66, with a change in price of +0.77. Similarly, Black Diamond Therapeutics Inc recorded 540,501 in trading volume during the last 100 days, posting a change of +21.83%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for BDTX stands at 0.19. Similarly, the long-term debt-to-equity ratio is also 0.17.

BDTX Stock Stochastic Average

Today, Black Diamond Therapeutics Inc’s raw stochastic average for the past 50 days stands at 96.65%, indicating a rise from the raw stochastic average of the last 20 days, which was 95.83%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 80.09% and 79.05% respectively.

BDTX Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 54.62% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 31.66%. Over the past 30 days, the price of BDTX has fallen by 42.92%. And in the last five days, it has surged by 1.99%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts